BioCyDex Overview

  • Year Founded
  • 2002

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • 2ndary - Private

BioCyDex General Information

Description

Operator of drug discovery and drug delivery company intended to provide horizontally integrated and cost-effective approaches to early-stage drug development. The company provides various services such as early-stage drug development, drug formulation, effective drug delivery system, and others, allowing medical professionals and researchers to get advanced drug development support with a variety of medical services.

Contact Information

Website
www.biocydex.net
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • 1, rue Georges Bonnet
  • Bât. 37
  • 86000 Poitiers
  • France
+33 05
Primary Industry
Drug Delivery
Other Industries
Drug Discovery
Vertical(s)
HealthTech
Corporate Office
  • 1, rue Georges Bonnet
  • Bât. 37
  • 86000 Poitiers
  • France
+33 05

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BioCyDex Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Secondary Transaction - Private 01-Jan-2023 Completed Generating Revenue
2. Later Stage VC 30-Oct-2009 Completed Generating Revenue
1. Angel (individual) 04-Aug-2006 $179K $179K Completed Generating Revenue
To view BioCyDex’s complete valuation and funding history, request access »

BioCyDex Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Ordinary Shares
Ordinary Shares
Ordinary Shares 90 $148.159781 $2311.29 $2311.29 1x $2311.29 1.36%
To view BioCyDex’s complete cap table history, request access »

BioCyDex Patents

  • 28

    Total Documents Applications and Grants

  • Total Patents Families

  • 9

    Granted

  • 4

    Pending

  • Expiring in next 12 mo

BioCyDex Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3099369-A1 Substituted cyclodextrin-metal complexes and uses thereof Pending 09-May-2018
EP-3567059-A1 Substituted cyclodextrin-metal complexes and uses thereof Inactive 09-May-2018
EP-3790905-A1 Substituted cyclodextrin-metal complexes and uses thereof Pending 09-May-2018
US-20210228577-A1 Substituted cyclodextrin-metal complexes and uses thereof Pending 09-May-2018
ES-2620827-T3 Compositions based on positively charged cyclodextrins to conserve cells, tissues or organs and their uses Active 08-Nov-2007 A61K31/724
To view BioCyDex’s complete patent history, request access »

Ready to get started?

Request a free trial

BioCyDex FAQs

  • When was BioCyDex founded?

    BioCyDex was founded in 2002.

  • Where is BioCyDex headquartered?

    BioCyDex is headquartered in Poitiers, France.

  • What industry is BioCyDex in?

    BioCyDex’s primary industry is Drug Delivery.

  • Is BioCyDex a private or public company?

    BioCyDex is a Private company.

  • What is BioCyDex’s current revenue?

    The current revenue for BioCyDex is .

  • How much funding has BioCyDex raised over time?

    BioCyDex has raised $542K.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »